As of March 2024 Catalyst Pharmaceuticals has a market cap of $1.90 Billion. This makes Catalyst Pharmaceuticals the world's 4205th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.90 B | 6.54% |
2023 | $1.79 B | -7.42% |
2022 | $1.93 B | 177.62% |
2021 | $0.69 B | 101.15% |
2020 | $0.34 B | -10.6% |
2019 | $0.38 B | 96.56% |
2018 | $0.19 B | -50.77% |
2017 | $0.40 B | 360.32% |
2016 | $87.04 M | -57.12% |
2015 | $0.20 B | -1.12% |
2014 | $0.20 B | 94.47% |
2013 | $0.10 B | 485.85% |
2012 | $18.01 M | -43.45% |
2011 | $31.86 M | 65.96% |
2010 | $19.2 M | 68.96% |
2009 | $11.36 M | -55.1% |
2008 | $25.3 M | -41.44% |
2007 | $43.22 M | -28.51% |
2006 | $60.45 M |
On Mar 27th, 2024 the market cap of Catalyst Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $382.26 B | 19,920.28% | ๐บ๐ธ USA |
Pfizer PFE | $157.78 B | 8,163.76% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $196.63 B | 10,198.13% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | $12.25 B | 541.62% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $14.68 M | -99.23% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $16.62 B | 770.51% | ๐บ๐ธ USA |